Thenewswire
Published September 23, 2026
NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with ...
Read the full story at Thenewswire
The U.S. patent applications cover proprietary combinations of NeuroThera's PEA technology with LSD , ketamine and ibogaine for potential.
Surfaced by this Google Alert
- LSD